MRKR - Marker Therapeutics GAAP EPS of -$3.58 beats by $0.02 revenue of $9.01M beats by $0.01M
2023-03-22 08:45:31 ET
- Marker Therapeutics press release ( NASDAQ: MRKR ): FY GAAP EPS of -$3.58 beats by $0.02 .
- Revenue of $9.01M (+626.6% Y/Y) beats by $0.01M .
-
At December 31, 2022, Marker had cash and cash equivalents of $11.8 million. The Company believes that its existing cash, cash equivalents and restricted cash will fund its operating expenses and capital expenditure requirements into the third quarter of 2023.
For further details see:
Marker Therapeutics GAAP EPS of -$3.58 beats by $0.02, revenue of $9.01M beats by $0.01M